Colfax's (CFX) Product Strength Aids Amid Cost & Supply Woes
- Colfax (CFX) benefits from solid product offerings and focus on innovation, healthy demand and acquisition synergies. Cost inflation and supply-chain woes are concerning.
- 01/17/2022
|
Colfax to Present at the 40th Annual JP Morgan Healthcare Conference
- Wilmington, DE, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, announced today that it will be presenting at the J.P. Morgan Healthcare Conference on January 12, at 3:00 pm (EST). A live presentation of this event will be available via Colfax's website at www.colfaxcorp.com under the “Investors” section. Replays will also be available on the Company's website following the event.
- 01/10/2022
|
Forget The Covid Apocalypse, Focus On Stocks That Closed Green After Friday's Monster Sell Off
- Sharp sell-offs can reveal great stock ideas if you surface the right stocks that contrary to the market action close positive. When picking names that close in the green, make sure they are well known and of a higher market cap. They tend to have sustainable rallies when they turn around.
- 11/28/2021
|
Colfax Corporation's (CFX) CEO Matt Trerotola on Q3 2021 Results - Earnings Call Transcript
- Colfax Corporation's (CFX) CEO Matt Trerotola on Q3 2021 Results - Earnings Call Transcript
- 11/07/2021
|
Colfax (CFX) Meets Earnings Estimates in Q3, Lowers View
- Colfax's (CFX) Q3 earnings reflect the impacts of improved sales, margin expansion, supply-chain woes and logistics issues. For 2021, it lowers earnings projections on high taxes and pandemic woes.
- 11/05/2021
|
Colfax (CFX) Q3 Earnings Match Estimates
- Colfax (CFX) delivered earnings and revenue surprises of 0.00% and 1.57%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
- 11/04/2021
|
Colfax Clocks 20% Sales Growth In Q3, Beats Estimates
- Colfax Corp (NYSE: CFX) reported third-quarter sales growth of 20% year-over-year to $965.89 million, +15% on an organic sales-per-day basis, beating the consensus of $958.430 million. Adjusted EPS improved to $0.54 from $0.41 in 3Q20, beating the consensus of $0.53.
- 11/04/2021
|
Starboard Value spots fresh opportunities for diversified tech company Colfax
- Starboard supports Colfax's plan to split into two businesses, but there are other ways to improve profitability.
- 10/30/2021
|
Colfax (CFX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Colfax (CFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 10/28/2021
|
Colfax Schedules Third Quarter 2021 Earnings Release and Conference Call
- WILMINGTON, DE, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it will issue a press release providing financial results for the third quarter of 2021 on the morning of Thursday, November 4, 2021. The Company will hold a conference call to discuss these results beginning at 8:00 a.m. Eastern on that day, which will be open to the public by calling +1-888-771-4371 (U.S. callers) and +1-847-585-4405 (International callers) and referencing the conference ID number 50243903 and through webcast via Colfax's website www.colfaxcorp.com under the “Investors” section.
- 10/18/2021
|
DJO® Expands Active, Adaptive Healing Offerings with Introduction of MedShape® DynaNail Hybrid™
- DALLAS--(BUSINESS WIRE)-- #djo--DJO® Expands Active, Adaptive Healing Offerings with Introduction of MedShape® DynaNail Hybrid™
- 09/22/2021
|
DJO® Introduces New EMPOWR Dual Mobility™ Hip System at AAOS
- AUSTIN, Texas--(BUSINESS WIRE)-- #djo--DJO, a leading global provider of medical technologies to get and keep people moving, today introduced its newest offering, EMPOWR Dual Mobility™.
- 08/31/2021
|
Colfax (CFX) Up 2.9% Since Last Earnings Report: Can It Continue?
- Colfax (CFX) reported earnings 30 days ago. What's next for the stock?
- 08/27/2021
|
4 Stocks Insiders Are Buying
- When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.
- 08/05/2021
|
CFX vs. NDSN: Which Stock Should Value Investors Buy Now?
- CFX vs. NDSN: Which Stock Is the Better Value Option?
- 07/30/2021
|
Colfax (CFX) Tops Q2 Earnings & Sales Estimates, Hikes View
- Colfax's (CFX) Q2 earnings increase y/y on the back of strengthening end markets and margin improvement. For 2021, the company raises earnings and free cash flow projections.
- 07/30/2021
|
Colfax Corp (CFX) CEO Matthew Trerotola on Q2 2021 Results - Earnings Call Transcript
- Colfax Corp (CFX) CEO Matthew Trerotola on Q2 2021 Results - Earnings Call Transcript
- 07/30/2021
|
Colfax Announces Pricing of Secondary Offering of 6,544,522 Shares of Common Stock
- WILMINGTON, DE, July 28, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (“Colfax” or the “Company”) (NYSE: CFX), a leading diversified technology company, announced today the pricing of an underwritten secondary offering by certain of its stockholders (the “Selling Stockholders”) of 6,544,522 shares of the Company's common stock at a public offering price of $43.90 per share. The shares are expected to be delivered on or about August 2, 2021, subject to customary closing conditions.
- 07/28/2021
|
Colfax (CFX) Surpasses Q2 Earnings and Revenue Estimates
- Colfax (CFX) delivered earnings and revenue surprises of 5.66% and 7.15%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 07/28/2021
|
Colfax Announces Secondary Offering of 6,544,522 Shares of Common Stock
- WILMINGTON, DE, July 28, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (“Colfax” or the “Company”) (NYSE: CFX), a leading diversified technology company, announced today that certain of its stockholders (the “Selling Stockholders”) have commenced an underwritten secondary offering of 6,544,522 shares of the Company's common stock.
- 07/28/2021
|
Will Colfax (CFX) Beat Estimates Again in Its Next Earnings Report?
- Colfax (CFX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 07/28/2021
|
A Preview Of Colfax's Earnings
- Colfax (NYSE:CFX) announces its next round of earnings this Thursday, July 29. Here is Benzinga's everything-that-matters guide for this Thursday's Q2 earnings announcement.
- 07/28/2021
|
A Preview Of Colfax's Earnings
- On Thursday, July 29, Colfax (NYSE:CFX) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release.
- 07/28/2021
|
Colfax Schedules Second Quarter 2021 Earnings Release and Conference Call
|
CFX or FLS: Which Is the Better Value Stock Right Now?
- CFX vs. FLS: Which Stock Is the Better Value Option?
- 07/14/2021
|
Colfax (CFX) Stock Up 19.3% YTD: What's Driving the Rally?
- Colfax (CFX) is poised to benefit from strong demand for its products, solid product portfolio, acquired assets and healthy cash flows.
- 07/14/2021
|
Artificial Intelligence Ranks Colfax Corp And Evertec Inc Among Today's Top Buys
- The Dow Jones rose 30 points, while the S&P 500 rose 0.1%, and Nasdaq was flat. Make the most of this market with today's Top Buys from Q.ai's artificial intelligence.
- 06/17/2021
|
Colfax's (CFX) CEO Matt Trerotola on Q1 2021 Results - Earnings Call Transcript
- Colfax's (CFX) CEO Matt Trerotola on Q1 2021 Results - Earnings Call Transcript
- 05/01/2021
|
Colfax (CFX) Q1 Earnings and Revenues Top Estimates
- Colfax (CFX) delivered earnings and revenue surprises of 12.82% and 4.49%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
- 04/29/2021
|
Colfax: Q1 Earnings Insights
- Shares of Colfax (NYSE:CFX) were flat in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 15.79% over the past year to $0.44, which beat the estimate of $0.40.
- 04/29/2021
|
Colfax Announces First Quarter 2021 Results
- ANNAPOLIS JUNCTION, MD, April 29, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its financial results for the first quarter of 2021.
- 04/29/2021
|
Colfax Schedules First Quarter 2021 Earnings Release and Conference Call
- Annapolis Junction, MD, April 14, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it will issue a press release providing financial results for the first quarter of 2021 on the morning of Thursday, April 29, 2021. The Company will hold a conference call to discuss these results beginning at 8:00 a.m. Eastern on that day, which will be open to the public by calling +1-877-303-7908 (U.S. callers) and +1-678-373-0875 (International callers) and referencing the conference ID number 1986324 and through webcast via Colfax's website www.colfaxcorp.com under the “Investors” section.
- 04/14/2021
|
Colfax (CFX) to Redeem $700M Worth Senior Notes Due 2024 & 2026
- Colfax (CFX) to redeem $700 million worth of senior notes that are due to expire in 2024 and 2026. The move will help the company to lower its debt balance.
- 03/26/2021
|
Colfax Announces Full Redemption of 6.000% Senior Notes due 2024 and $100 Million Partial Redemption of 6.375% Senior Notes due 2026
- Annapolis Junction, MD, March 25, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (“Colfax” or the “Company”) (NYSE: CFX), a leading diversified technology company, announced today that it has given notice of its intention to redeem $600 million principal amount representing all of its outstanding 6.000% Senior Notes due 2024 (CUSIP Numbers 15723RAA2, U1581TAA6) (the “2024 Notes”) and $100 million of the $400 million outstanding principal amount of its 6.375% Senior Notes due 2026 (CUSIP Numbers 15723RAC8, U1581TAB4) (the “2026 Notes” and, together with the 2024 Notes, the “Notes”) on April 24, 2021 (the “Redemption Date”). The 2024 Notes will be redeemed at a redemption price of 103.000% of the principal amount of the 2024 Notes and the 2026 Notes will be redeemed at a redemption price of 106.375% of the principal amount of the 2026 Notes to be redeemed, plus, in each case, accrued and unpaid interest to, but not including, the Redemption Date. On and after the Redemption Date, interest will cease to accrue on the 2024 Notes and the portion of the 2026 Notes selected for redemption. After the Redemption Date, upon surrender of the 2026 Notes, new 2026 Notes in principal amount equal to the unredeemed portion of the original 2026 Notes will be issued in the names of the holders thereof.
- 03/25/2021
|
Why Is Colfax (CFX) Up 10.6% Since Last Earnings Report?
- Colfax (CFX) reported earnings 30 days ago. What's next for the stock?
- 03/20/2021
|
Colfax Announces Pricing of Public Offering of 14,000,000 Shares of Common Stock
- ANNAPOLIS JUNCTION, MD, March 16, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (“Colfax” or the “Company”) (NYSE: CFX), a leading diversified technology company, announced today the pricing of an underwritten registered public offering of 14,000,000 shares of its common stock at a public offering price of $46.00 per share. The underwriters have a 30-day option to purchase up to an additional 2,100,000 shares from the Company at the public offering price. The Company estimates that the net proceeds from the offering, after deducting the underwriting discounts and commissions and other estimated offering expenses, will be approximately $618.4 million, or $711.3 million if the underwriters exercise their option to purchase additional shares in full. The shares are expected to be delivered on or about March 19, 2021, subject to customary closing conditions.
- 03/16/2021
|
Colfax (CFX) Commences Public Offering of 14M Common Shares
- Colfax (CFX) offers 14 million common shares to the public in an underwritten offer. The funds raised will be used for funding general corporate purposes and working capital needs.
- 03/16/2021
|
Colfax Announces Public Offering of 14,000,000 Shares of Common Stock
- ANNAPOLIS JUNCTION, MD, March 15, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (“Colfax” or the “Company”) (NYSE: CFX), a leading diversified technology company, announced today that it has commenced an underwritten registered public offering of 14,000,000 shares of its common stock. In addition, Colfax intends to grant the underwriters a 30-day option to purchase up to an additional 2,100,000 shares of its common stock. The offering is subject to market and other customary conditions.
- 03/15/2021
|
Colfax (CFX) Plans to Split Businesses Into Separate Companies
- Colfax's (CFX) plan of dividing its fabrication technology and medical technology businesses into two separate companies will likely unlock significant values for each of its businesses.
- 03/08/2021
|
Colfax (CFX) Moves 5.8% Higher: Will This Strength Last?
- Colfax (CFX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- 03/05/2021
|
Repeat: Colfax Announces Intention to Separate Into Two Independent Public Companies
- Annapolis Junction, Maryland, March 04, 2021 (GLOBE NEWSWIRE) -- – Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its intention to separate its fabrication technology and specialty medical technology businesses into two differentiated, independent, and publicly-traded companies. The separation is intended to be structured in a tax-free manner and is targeted to be completed in the first quarter of 2022.
- 03/04/2021
|
Colfax Announces Intention to Separate Into Two Independent Public Companies
- Annapolis Junction, Maryland, March 04, 2021 (GLOBE NEWSWIRE) -- – Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its intention to separate its fabrication technology and specialty medical technology businesses into two differentiated, independent, and publicly-traded companies. The separation is intended to be structured in a tax-free manner and is targeted to be completed in the first quarter of 2022.
- 03/04/2021
|
Philip Okala Appointed to Colfax Board of Directors
- Annapolis Junction, MD, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it has appointed Philip Okala, Chief Operating Officer of the University of Pennsylvania Health System, to its Board of Directors. This appointment increases the size of Colfax's Board of Directors to eleven members.
- 02/22/2021
|
Colfax (CFX) Q4 Earnings Top Estimates, 2021 View Impressive
- Colfax's (CFX) Q4 earnings decrease year over year, reflecting the impacts of weak sales generation and a decline in margins. For 2021, it anticipates y/y revenue and earnings growth.
- 02/19/2021
|
Colfax Corporation (CFX) CEO Matt Trerotola on Q4 2020 Results - Earnings Call Transcript
- Colfax Corporation (CFX) CEO Matt Trerotola on Q4 2020 Results - Earnings Call Transcript
- 02/18/2021
|
Colfax (CFX) Surpasses Q4 Earnings Estimates
- Colfax (CFX) delivered earnings and revenue surprises of 4.08% and -0.25%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
- 02/18/2021
|
Colfax Announces Fourth Quarter 2020 Results and 2021 Growth Outlook
- • Reported $0.29 EPS from continuing operations and achieved $0.51 of adjusted EPS• Recently acquired two high-growth, high-gross margin medical technology businesses • Announced 2021 outlook with expectations for significant revenue, profit and cash flow growth • Scheduled Investor Day for Thursday, March 11, 2021
- 02/18/2021
|
Colfax Schedules Fourth Quarter 2020 Earnings Release and Conference Call
- Annapolis Junction, MD, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it will issue a press release providing financial results for the fourth quarter of 2020 on the morning of Thursday, February 18, 2021. The Company will hold a conference call to discuss these results beginning at 8:00 a.m. Eastern on that day, which will be open to the public by calling +1-877-303-7908 (U.S. callers) and +1-678-373-0875 (International callers) and referencing the conference ID number 3753307 and through webcast via Colfax's website www.colfaxcorp.com under the “Investors” section.
- 01/29/2021
|
Colfax's (CFX) Unit Closes Buyout of Trilliant Surgical
- Colfax (CFX) arm DJO closes buyout of Trilliant Surgical, which will boost its product offerings and growth prospects in the foot and ankle surgery market.
- 01/21/2021
|
5 Industrial Stocks Near 52-Week Highs That Can Scale Higher
- The industrial sector is gearing up for growth in 2021. ParkerHannifin (PH), Fortune Brands (FBHS), Reliance Steel (RS), Rexnord (RXN) and Colfax (CFX) are performing well and are set to grow.
- 01/13/2021
|
Is Colfax (CFX) a Profitable Stock for Value Investors Now?
- Let's see if Colfax (CFX) stock is a good choice for value-oriented investors right now from multiple angles.
- 01/08/2021
|
Chuck Royce's Firm's Top 5 Sells of the 3rd Quarter
- Royce Investment Partners has revealed its portfolio for the third quarter, including several large reductions in holdings. These reductions include Ares Management Corp. (NYSE:ARES), Scholastic Corp. (NASDAQ:SCHL), Tennant Co. (NYSE:TNC), BMC Stock Holdings Inc. (NASDAQ:BMCH) and Quaker Chemical Corp. (NYSE:KWR).
- 11/25/2020
|
Colfax Corporation (CFX) CEO Matt Trerotola on Q3 2020 Results - Earnings Call Transcript
- Colfax Corporation (CFX) CEO Matt Trerotola on Q3 2020 Results - Earnings Call Transcript
- 10/29/2020
|
Colfax Reports Third Quarter 2020 Results
- ANNAPOLIS JUNCTION, MD, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its financial results for the third quarter of 2020.
- 10/29/2020
|
Global Waterjet Cutting Machine Consumables Industry (2020 to 2027) - Market Trajectory & Analytics - ResearchAndMarkets.com
|
DJO® Announces New Stemless Shoulder Offering – the AltiVate® Anatomic CS EDGE™
- DJO, LLC (“DJO” or the “Company”), a leading global provider of medical technologies to get and keep people moving, today announced the launch of the
- 09/30/2020
|
Neuberger Berman Group LLC Grows Stock Holdings in Colfax Corp (NYSE:CFX)
- Neuberger Berman Group LLC boosted its holdings in Colfax Corp (NYSE:CFX) by 7.7% in the second quarter, Holdings Channel reports. The institutional investor owned 22,264 shares of the industrial products company’s stock after acquiring an additional 1,583 shares during the quarter. Neuberger Berman Group LLC’s holdings in Colfax were worth $621,000 as of its most […]
- 09/29/2020
|
Nuveen Asset Management LLC Purchases 247,958 Shares of Colfax Corp (NYSE:CFX)
- Nuveen Asset Management LLC lifted its position in Colfax Corp (NYSE:CFX) by 75.4% in the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 576,971 shares of the industrial products company’s stock after acquiring an additional 247,958 shares during the period. Nuveen Asset Management LLC owned 0.49% of […]
- 09/29/2020
|
Engineers Gate Manager LP Increases Stock Holdings in Colfax Corp (NYSE:CFX)
- Engineers Gate Manager LP boosted its stake in Colfax Corp (NYSE:CFX) by 51.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 23,400 shares of the industrial products company’s stock after acquiring an additional 7,962 shares during the period. Engineers Gate […]
- 09/22/2020
|
Worldwide Outlook on the Compression Therapy Industry to 2025 - ResearchAndMarkets.com
|
Extremities Could Become A STAR Performer For Colfax
- Stryker has revealed through regulatory filings that it has reached an agreement to sell its very competitive STAR total ankle portfolio to Colfax, but no financial terms have been revealed.
- 09/15/2020
|
Colfax's Rate Of Recovery Will Demonstrate The Strength Of Newly Transformed Portfolio
- Colfax’s exit from volatile oil and gas business and entry into more defensive medical technology business has put it in a good position to weather the current coronavirus slowdown.
- 08/28/2020
|
Global Waterjet Cutting Machines Market Analysis Highlights the Impact of COVID-19 2020-2024 | Increasing Demand from Automotive Industry to Boost Market Growth | Technavio
- The Global Waterjet Cutting Machines Market will grow by $ 410.60 mn during 2020-2024
- 08/26/2020
|
Is Now An Opportune Moment To Examine Colfax Corporation (NYSE:CFX)?
- Colfax Corporation (NYSE:CFX), is not the largest company out there, but it led the NYSE gainers with a relatively...
- 08/10/2020
|
At US$33.31, Is It Time To Put Colfax Corporation (NYSE:CFX) On Your Watch List?
- While Colfax Corporation (NYSE:CFX) might not be the most widely known stock at the moment, it saw a significant share...
- 08/10/2020
|
Colfax (CFX) Tops Q2 Earnings Estimates, Gives Impressive View
- Colfax's (CFX) Q2 results reflect the adverse impacts of the pandemic on product demand and forex woes. It predicts generating sequentially higher profits and positive cash flow in Q3.
- 08/07/2020
|
Global Lateral Epicondylitis (Tennis Elbow) Market 2020-2026 by Treatment Type, End User and Region - ResearchAndMarkets.com
|
DJO® Revolutionizes the Orthopedic Journey with the Launch of Motion iQ™
- DJO, LLC ("DJO" or the "Company"), a leading global provider of medical technologies to get and keep people moving, introduces Motion iQ™, an innovative new software solution designed to transform the surgical journey by connecting the surgeon, care team and patient throughout the continuum of care.
- 08/06/2020
|
Colfax (CFX) Beats Q2 Earnings and Revenue Estimates
- Colfax (CFX) delivered earnings and revenue surprises of 50.00% and 2.91%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- 08/06/2020
|
Colfax Reports Second Quarter 2020 Results
- • Achieved objectives to address COVID-19 impacts, including generating positive cash flow• Reported $(0.03) EPS from continuing operations and achieved $0.09 of adjusted EPS • Sequentially improved sales rates each month during the quarter• Continued investments in innovation support long-term growth plans ANNAPOLIS JUNCTION, MD, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its financial results for the second quarter of 2020.The Company reported a net loss from continuing operations of $3.6 million, or $0.03 per share, in the quarter, compared to net income of $0.01 in the prior year quarter. On an adjusted basis, the Company reported earnings of $0.09 per diluted share, compared to $0.54 in the second quarter of 2019. Adjustments to reported earnings are included in the reconciliation schedules provided.For the second quarter, Colfax reported net sales of $620 million, 32% lower than the previous year’s quarter due to the current year impact from COVID-19-related demand reductions. Excluding the impact from currency translation adjustments, organic sales decreased 28%. The Company realized sequential improvements for each month in the second quarter, with June organic sales 19% lower than the prior year. The Company also reported second quarter adjusted EBITA of $45 million, or 7.3% of sales, as temporary savings measures partially mitigated the impact from the volume declines.During the second quarter the Company generated operating cash flow of $37 million and free cash flow of $18 million, and repaid $300 million of its credit agreement borrowings. The Company completed the second quarter with 4.2 times net leverage and ample liquidity, including $66 million of cash and $1.2 billion of capacity under its credit agreement and other facilities.“During the quarter we stayed focused on our principal objectives of keeping associates safe, maintaining supply to our customers, and protecting Colfax’s financial health,” said Matt Trerotola, Colfax President and CEO. “I’m very pleased with the resiliency of our businesses and teams through this challenging period. We deployed temporary measures and successfully drove Q2 decremental margin to 28%. Sales per day rates sequentially improved each month, including July. We expect to pace our temporary cost measures with sales levels in the third quarter to deliver sequentially higher profit and remain cash flow positive.“We continue to pursue our growth agenda in this softer demand environment. During the first half of 2020, we launched over 35 new products in our FabTech business, including the WeldCloud Notes document management software to enhance our digital solution tools. Our MedTech business product launches include today’s announcement of Motion iQ™, a patient relationship management tool that seamlessly connects clinicians and patients across the orthopedic care continuum. We are well-positioned to resume our long-term growth momentum as market conditions improve.”The Company also reported that its Medical Technology segment sales decreased 35% in the quarter on a reported basis and 34% organically versus the prior year period. Fabrication Technology segment sales decreased 30% in the quarter on a reported basis and 25% organically versus the prior year period. Both segments recorded sequential improvements each month during the quarter, with June Medical Technology organic sales declining 16% and Fabrication Technology organic sales declining 20%. The Medical Technology segment reported adjusted EBITA margins of 3.2%, versus 16.5% in the comparable prior year period, and the Fabrication Technology segment reported adjusted EBITA margins of 12.6%, compared to 15.2% in the prior year second quarter.Given the uncertainties of customer demand due to the COVID-19 pandemic, Colfax is not providing financial guidance for 2020.Conference Call and WebcastThe Company will hold a conference call to discuss these results beginning at 8:00 a.m. Eastern today, which will be open to the public by calling +1-877-303-7908 (U.S. callers) and +1-678-373-0875 (International callers) and referencing the conference ID number 6196870 and through webcast via Colfax’s website www.colfaxcorp.com under the “Investors” section. Access to a supplemental slide presentation can also be found at the Colfax website under the same heading. Both the audio of this call and the slide presentation will be archived on the website later today and will be available until the next quarterly call.About Colfax CorporationColfax Corporation is a leading diversified technology company that provides orthopedic and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. Colfax believes that its brands are among the most highly recognized in each of the markets that it serves. The Company uses its Colfax Business System (“CBS”), a comprehensive set of tools, processes and values, to create superior value for customers, shareholders and associates. Colfax’s common stock is traded on the NYSE under the ticker “CFX.”Non-GAAP Financial Measures and Other AdjustmentsColfax has provided in this press release financial information that has not been prepared in accordance with accounting principles generally accepted in the United States of America (“non-GAAP”). These non-GAAP financial measures are adjusted net income from continuing operations, adjusted net income margin from continuing operations, adjusted net income per diluted share from continuing operations, adjusted EBITA (earnings before interest, taxes and amortization), adjusted EBITA margin, organic sales growth, and free cash flow. Colfax also provides adjusted EBITA and adjusted EBITA margin on a segment basis.Adjusted net income from continuing operations represents net income (loss) from continuing operations excluding restructuring and other related charges, European Union Medical Device Regulation (“MDR”) costs, debt extinguishment charges, acquisition-related amortization and other non-cash charges, and strategic transaction costs. Colfax also presents adjusted net income margin from continuing operations, which is subject to the same adjustments as adjusted net income from continuing operations.Adjusted net income per diluted share from continuing operations represents adjusted income from continuing operations divided by the number of adjusted diluted weighted average shares. Both GAAP and non-GAAP diluted net income per share data is computed based on weighted average shares outstanding and, if there is net income from continuing operations (rather than net loss) during the period, the dilutive impact of share equivalents outstanding during the period. Diluted weighted average shares outstanding and adjusted diluted weighted average shares outstanding are calculated on the same basis except for the net income or loss figure used in determining whether to include such dilutive impact.Adjusted EBITA represents net income (loss) from continuing operations excluding restructuring and other related charges, MDR costs, acquisition-related amortization and other non-cash charges, and strategic transaction costs, as well as income tax expense(benefit) and interest expense, net. Colfax presents adjusted EBITA margin, which is subject to the same adjustments as adjusted EBITA. Further, Colfax presents adjusted EBITA (and adjusted EBITA margin) on a segment basis, where we exclude the impact of strategic transaction costs and acquisition-related amortization and other non-cash charges from segment operating income.Core or organic sales growth (decline) excludes the impact of acquisitions and foreign exchange rate fluctuations.Free cash flow represents cash flow from operating activities less purchases of property, plant and equipment.These non-GAAP financial measures assist Colfax management in comparing its operating performance over time because certain items may obscure underlying business trends and make comparisons of long-term performance difficult, as they are of a nature and/or size that occur with inconsistent frequency or relate to discrete restructuring plans that are fundamentally different from the ongoing productivity improvements of the Company. Colfax management also believes that presenting these measures allows investors to view its performance using the same measures that the Company uses in evaluating its financial and business performance and trends.Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of non-GAAP financial measures presented above to GAAP results has been provided in the financial tables included in this press release.CAUTIONARY NOTE CONCERNING FORWARD LOOKING STATEMENTSThis press release may contain forward-looking statements, including forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning Colfax’s plans, objectives, expectations and intentions and other statements that are not historical or current fact. Forward-looking statements are based on Colfax’s current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements.
- 08/06/2020
|
COVID-19 Impacts: Welding Equipment Market will Accelerate at a CAGR of almost 5% through 2020-2024 | Use of Friction Stir Welding Technology to Boost Growth | Technavio
- The Global Welding Equipment Market will grow by USD 2.54 bn during 2020-2024
- 08/05/2020
|
Colfax (CFX) Scheduled to Post Earnings on Thursday
- Colfax (NYSE:CFX) will be releasing its earnings data before the market opens on Thursday, August 6th. Analysts expect Colfax to post earnings of $0.04 per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link. Colfax (NYSE:CFX) last posted its quarterly earnings results on […]
- 08/04/2020
|
Analysts Estimate Colfax (CFX) to Report a Decline in Earnings: What to Look Out for
- Colfax (CFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/30/2020
|
Colfax (CFX) Shares Gain 41% in 3 Months: What's Driving It?
- Colfax (CFX), with 41% growth in shares in the past three months, benefits from the overall revival in the broader market, buyout impacts, solid product offerings and cost-saving measures.
- 07/20/2020
|
Can Colfax (CFX) Keep the Earnings Surprise Streak Alive?
- Colfax (CFX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 07/17/2020
|
Colfax Schedules Second Quarter 2020 Earnings Release and Conference Call | MarketScreener
|
Colfax Schedules Second Quarter 2020 Earnings Release and Conference Call
- Annapolis Junction, MD, July 14, 2020 -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it will issue a press release providing.
- 07/14/2020
|
Colfax Schedules Second Quarter 2020 Earnings Release and Conference Call
- Annapolis Junction, MD, July 14, 2020 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it will issue a press release providing financial results for the second quarter of 2020 on the morning of Thursday, August 6, 2020. The Company will hold a conference call to discuss these results beginning at 8:00 a.m. Eastern on that day, which will be open to the public by calling +1-877-303-7908 (U.S. callers) and +1-678-373-0875 (International callers) and referencing the conference ID number 6196870 and through webcast via Colfax’s website www.colfaxcorp.com under the “Investors” section.Colfax’s financial results press release and supplemental information referenced on the call, if any, for the second quarter of 2020 will be available under the “Investors” section of Colfax’s website prior to the conference call. A link to a replay of the call will also be available on the Colfax website later that day.About Colfax CorporationColfax Corporation is a leading diversified technology company that provides orthopedic and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. Colfax believes that its brands are among the most highly recognized in each of the markets that it serves. The Company uses its Colfax Business System (“CBS”), a comprehensive set of tools, processes and values, to create superior value for customers, shareholders and associates. Colfax’s common stock is traded on the NYSE under the ticker “CFX.” Additional information about Colfax is available at www.colfaxcorp.com. CONTACT: Investor Contact: Mike Macek Vice President, Finance Colfax Corporation +1 (302) 252-9129 investorrelations@colfaxcorp.com
- 07/14/2020
|
Did Hedge Funds Make The Right Call On Colfax Corporation (CFX) ?
- How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […]
- 07/14/2020
|
Global $6.3 Bn Pain Management Devices Market and Competition Analysis 2016-2026 - ResearchAndMarkets.com
|
Tower Research Capital LLC TRC Takes Position in Colfax Corp (NYSE:CFX)
- Tower Research Capital LLC TRC purchased a new stake in shares of Colfax Corp (NYSE:CFX) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 3,244 shares of the industrial products company’s stock, valued at approximately $64,000. Other hedge funds have also recently made […]
- 07/02/2020
|
Bay Area's momentum in reopening economy disrupted as counties freeze some plans
- The Bay Area’s march to reopen the economy was disrupted on Friday when San Francisco and Marin counties — concerned with a jump in new coronavirus infections — abruptly halted plans to open some businesses and Contra Costa County said it is considering a similar move.
- 06/27/2020
|
Nuveen Asset Management LLC Has $6.51 Million Stock Position in Colfax Corp (NYSE:CFX)
- Nuveen Asset Management LLC grew its stake in Colfax Corp (NYSE:CFX) by 6.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 329,013 shares of the industrial products company’s stock after purchasing an additional 21,315 shares during the quarter. Nuveen Asset Management […]
- 06/26/2020
|
June 26 coronavirus news
- The coronavirus pandemic has brought countries to a standstill. In many places, as countries reopen, Covid-19 cases are on the rise. Follow here for the latest.
- 06/26/2020
|
SF gets state OK to reopen hair salons, outdoor bars, zoo
- San Francisco given approval to begin allowing the reopening of hair salons, barber shops, nail salons, massage establishments, tattoo studios, outdoor bars, outdoor museums and zoo.
- 06/26/2020
|
Brokerages Anticipate Colfax Corp (NYSE:CFX) to Post $0.03 EPS
- Equities analysts expect that Colfax Corp (NYSE:CFX) will report $0.03 earnings per share for the current quarter, Zacks reports. Seven analysts have made estimates for Colfax’s earnings. The highest EPS estimate is $0.08 and the lowest is ($0.08). Colfax posted earnings per share of $0.64 during the same quarter last year, which would suggest a […]
- 06/25/2020
|
Insights & Forecast with Potential Impact of COVID-19 - Hydrogen Compressor Market 2020-2024 | Growing Focus on Using Hydrogen in Refineries to Boost Growth | Technavio
- The Global Hydrogen Compressor Market will grow by USD 648.74 mn during 2020-2024
- 06/25/2020
|
Rigid Knee Braces Market to Surpass US$ 1,166.8 Million globally by 2027, Says Coherent Market Insights
- Global rigid knee braces market is expected to exhibit a CAGR of 4.2% during the forecast period (2020-2027),
- 06/24/2020
|
NEOGENOMICS INC : Change in Directors or Principal Officers (form 8-K) | MarketScreener
|
A Director at Colfax (NYSE: CFX) is Selling Shares - Markets
- Yesterday, a Director at Colfax (CFX – Research Report), Rajiv Vinnakota, sold shares of CFX for $49.39K. See today’s analyst
- 06/17/2020
|
Investing Lessons From Arnold Van Den Berg
- Three investing lessons I've learned from Arnold Van Den Berg Continue reading...
- 06/16/2020
|
Canada Pension Plan Investment Board Raises Position in Colfax Corp (NYSE:CFX)
- Canada Pension Plan Investment Board lifted its stake in shares of Colfax Corp (NYSE:CFX) by 53.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 22,811 shares of the industrial products company’s stock after purchasing an additional 7,928 shares during the […]
- 06/16/2020
|
Parametric Portfolio Associates LLC Purchases 72,854 Shares of Colfax Corp (NYSE:CFX)
- Parametric Portfolio Associates LLC grew its position in Colfax Corp (NYSE:CFX) by 12.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 664,173 shares of the industrial products company’s stock after acquiring an additional 72,854 shares during the period. Parametric Portfolio Associates LLC’s […]
- 06/14/2020
|
Burden of COVID-19 on the Market & Rehabilitation Plan| Metal Cutting Tools Market 2020-2024 | Growth in Automotive Industry to Boost Growth | Technavio
- The Global Metal Cutting Tools Market will grow by USD 10.24 bn during 2020-2024
- 06/12/2020
|
COVID-19 Impact and Recovery Analysis- Metal Machining Market 2020-2024 | Demand from Oil & Gas Sector to Boost Growth | Technavio
- Technavio has been monitoring the metal machining market and it is poised to grow by USD 14.76 billion during 2020-2024, progressing at a CAGR of 4% during...
- 06/11/2020
|
COVID-19 Impact and Recovery Analysis- Metal Machining Market 2020-2024 | Demand from Oil & Gas Sector to Boost Growth | Technavio
- The Global Metal Machining Market will grow by USD 14.76 bn during 2020-2024
- 06/11/2020
|
Several of industrial companies are trading lower amid market weakness as investors await today's Federal Reserve decision and update on the state of the economy. Markets have sold off over the past few sessions following recent surge.
|
Tracking Wallace Weitz's Weitz Investment Management Portfolio - Q1 2020 Update (MUTF:WPVLX)
- Wallace Weitz's 13F portfolio value decreased from $2.55B to $1.88B this quarter. The number of positions increased from 68 to 69. Weitz Investment Management a
- 06/09/2020
|
Why Is Colfax (CFX) Up 22.4% Since Last Earnings Report?
- Colfax (CFX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- 06/06/2020
|
Is Colfax Corporation (CFX) Going to Burn These Hedge Funds?
- Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional. In the following paragraphs, we find out […]
- 06/05/2020
|
Shares of several industrial companies are trading higher following strong US jobs numbers and continued optimism surrounding the reopening of the US economy. These have led to hopes of an economic rebound and an uptick in production/shipping activity.
|
COVID-19 Impact and Recovery Analysis - Knee Replacement Market 2020-2024 | Rise in Orthopedic Diseases to Boost Growth | Technavio
- The Global Knee Replacement Market will grow by USD 2.26 bn during 2020-2024
- 06/03/2020
|
DJO® Launches New DonJoy® X-ROM™ Post-Op Knee Brace
- DJO®, a leading global provider of medical technologies to get and keep people moving, introduces the new DonJoy® X-ROM™ Post-Op Knee Brace. Featuring DonJoy’s most advanced range of motion (ROM) protection and improved user-friendly design for faster, easier application and adjustment, the X-ROM™ brace helps patients recover from ACL repair and other knee surgeries with improved confidence, comfort and stability.
- 06/01/2020
|
DJO® Launches New DonJoy® X-ROM™ Post-Op Knee Brace
- DJO®, a leading global provider of medical technologies to get and keep people moving, introduces the new DonJoy® X-ROM™ Post-Op Knee Brace. Featuring
- 06/01/2020
|
Colfax (CFX) Declines 23% YTD: What's Hurting the Stock?
- Colfax (CFX), with a 23% decline in shares so far in 2020, faces the adverse impacts of the pandemic. High debts and forex woes are other concerns. However, cost-reduction actions might aid.
- 05/29/2020
|
Colfax (CFX) Declines 23% YTD: What's Hurting the Stock?
|
Edited Transcript of CFX earnings conference call or presentation 7-May-20 12:00pm GMT
- Q1 2020 Colfax Corp Earnings Call
- 05/27/2020
|
Shares of several industrial companies are trading higher in sympathy with the overall market as equities rally on coronavirus vaccine hopes as well as a pickup in economic activity as some US states reopen businesses.
|
Research Report with COVID-19 Forecasts-Global Orthopedic Device Market 2020-2024 | Evolving Opportunities with CONMED Corp. and DJO Global Inc. | Technavio
- The orthopedic device market size has the potential to grow by USD 6.07 million during 2020-2024
- 05/21/2020
|
Coronavirus testing slow to come to nursing homes, despite 35% of COVID-19 deaths
- The task of testing everyone in nursing homes is monumental. Testing an individual is relatively quick and straightforward, though uncomfortable. At drive-through and walk-up testing sites, it typically takes just a few minutes to collect a nasal sample. But testing hundreds of residents and thousands of workers quickly becomes a logistical nightmare.
- 05/20/2020
|
Shares of several industrial companies are trading higher amid market strength as news from a Moderna trial stoked optimism about a potential coronavirus vaccine, which has raised hopes of an economic rebound.
|
Is Colfax (CFX) Stock Worth Your Attention Right Now?
- Alphyn Capital recently released its Q1 2020 Investor Letter, a copy of which you can download below. The fund posted a return of -21.7% for the quarter, underperforming its benchmark, the S&P; 500 Index which returned -19.6% in the same quarter. You should check out Alphyn Capital’s top 5 stock picks for investors to buy […]
- 05/13/2020
|
Weitz Investment Exits Booking, Trims Expedia
- Firm's largest sales of the 1st quarter Continue reading...
- 05/12/2020
|
DJO® Announces Six-Month Free Access to the OaraScore® Outpatient Risk Assessment Tool
- DJO®, a leading provider of medical technologies designed to get and keep people moving, announced today that OaraScore®, DJO’s industry leading patient risk assessment algorithm, now will be available with a six-month free trial for all new users.
- 05/12/2020
|
Weitz Investment Exits Booking, Trims Expedia
|
Colfax Corporation (CFX) CEO Matthew Trerotola on Q1 2020 Results - Earnings Call Transcript
- Colfax Corporation (NYSE:CFX) Q1 2020 Results Earnings Conference Call May 07, 2020, 08:00 AM ET Company Participants Michael Macek - Vice President, Finance Ma
- 05/10/2020
|
Stifel Maintains Buy on Colfax, Raises Price Target to $32
|
Colfax (CFX) Beats Q1 Earnings Estimates, Withdraws View
- Colfax's (CFX) Q1 results reflect the adverse impacts of the pandemic and contributions from the DJO Global buyout. It withdraws projections for 2020, while expects demand to be the lowest in the second quarter.
- 05/08/2020
|
Morgan Stanley Maintains Equal-Weight on Colfax, Raises Price Target to $28
|
Citigroup Maintains Sell on Colfax, Raises Price Target to $21
|
U.S. RESEARCH ROUNDUP-Becton Dickinson, Epam Systems, PayPal Holdings
- Wall Street securities analysts on Friday revised their ratings and price targets on several
U.S.-listed companies, including Becton Dickinson, Epam Systems and PayPal Holdings.
HIGHLIGHTS
* Becton Dickinson and Co : Citigroup raises price target to $260 from $234
* Carrols Restaurant Group Inc : Craig-Hallum raises to buy from hold; raises target price to $5 from $3.75
* Computer Programs and Systems Inc : Cantor Fitzgerald raises to overweight from neutral
* Epam Systems Inc : Citigroup raises price target to $265 from $245
* PayPal Holdings Inc : Citigroup raises price target to $145 from $131
Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock entries are in alphabetical
order.
* Aaron's Inc : Keybanc cuts target price to $55 from $66
* Aaron's Inc : Raymond James cuts target price to $50 from $60
* Aaron's Inc : Stephens raises target price to $45 from $26
* Abeona Therapeutics Inc : RBC cuts target price to $7 from $11
* Acceleron pharma Inc : Credit Suisse raises target price to $123 from $99
* ACI Worldwide Inc : Canaccord Genuity cuts target price to $35 from $44
* Acushnet Holdings Corp : Jefferies raises target price to $25 from $24
* Acushnet Holdings Corp : JP Morgan raises target price to $30 from $27
* Adtran Inc : Cowen and Company raises price target to $13 from $9
* Aeglea Bio Therapeutics Inc : Needham cuts price target to $11 from $14
* Aerie Pharmaceuticals Inc : Citigroup cuts price target to $38 from $39
* Agco Corp : Citigroup cuts price target to $55 from $57
* AIG : KBW raises target price to $36 from $35
* Alaska Air Group Inc : Credit Suisse cuts target price to $51 from $82
* Allison Transmission Holdings Inc : Citigroup raises price target to $39 from $38
* Allscripts Healthcare Solutions : Cantor Fitzgerald cuts PT to $6 from $8
* Alteryx Inc : Guggenheim cuts target price to $130 from $160
* American Airlines : Credit Suisse cuts target price to $4 from $26
* Ameriprise Financial Inc : Credit Suisse raises target price to $165 from $153
* Ameriprise Financial Inc : Piper Sandler raises target price to $150 from $130
* Amerisourcebergen Corp : Baird raises target price to $115 from $109
* Amerisourcebergen Corp : Mizuho raises target price to $90 from $85
* Amtech Systems Inc : Cowen and Company raises target price to $7.50 from $7
* Angi Homeservices Inc : Needham raises target price to $11 from $8
* Ani Pharmaceuticals Inc : Guggenheim cuts target price to $48 from $58
* Ansys Inc : RBC raises target price to $260 from $230
* Anthem Inc : Bernstein raises target price to $357 from $342
* Appian Corp : Cowen and Company raises price target to $44 from $39
* Applied Optoelectronics Inc : D.A. Davidson raises target price to $12 from $10
* Applied Optoelectronics Inc : Piper Sandler raises target price to $10 from $7.50
* Aptiv Plc : Citigroup raises price target to $84 from $67
* ArcelorMittal SA : Keybanc raises target price to $15 from $13
* Arcturus Therapeutics Holdings Inc : Baird raises target price to $44 from $26
* Arcturus Therapeutics Holdings Inc : Guggenheim raises target price to $51 from $41
* Ares Capital Corp : Citigroup raises price target to $15 from $13
* Athersys Inc : Needham cuts price target to $5 from $6
* Atlas Air Worldwide Holdings Inc : Cowen and Company raises PT to $44 from $40
* Avalara Inc : Canaccord Genuity raises target price to $115 from $105
* Avalara Inc : JP Morgan raises target price to $120 from $104
* Avalara Inc : Mizuho raises price target to $120 from $85
* Avalara Inc : Piper Sandler raises target price to $113 from $90
* Avalonbay Communities Inc : Stifel raises target price to $176 from $171
* Avrobio Inc : Guggenheim raises target price to $50 from $49
* Axalta Coating Systems Ltd : RBC raises target price to $21 from $20
* Bausch Health Companies Inc : Piper Sandler cuts target price to $32 from $34
* Beacon Roofing Supply Inc : SunTrust Robinson raises target price to $26 from $24
* Beacon Roofing Supply Inc : Wedbush raises target price to $23 from $16
* Becton Dickinson and Co : Citigroup raises price target to $260 from $234
* Becton Dickinson and Co : Evercore ISI raises target price to $270 from $255
* Beyond Meat Inc : Berenberg raises price target to $125 from $115
* Bill.Com Holdings Inc : Canaccord Genuity raises target price to $65 from $50
* Bill.Com Holdings Inc : Jefferies raises target price to $70 from $45
* Bill.Com Holdings Inc : Keybanc raises target price to $76 from $60
* Bill.Com Holdings Inc : Needham raises target price to $90 from $55
* Biomarin Pharmaceutical Inc : Canaccord Genuity raises PT to $119 from $108
* BJ's Restaurants Inc : Wedbush cuts target price to $32 from $39
* Booking Holdings Inc : Credit Suisse raises target price to $1,810 from $1,790
* Booking Holdings Inc : Jefferies cuts target price to $1300 from $1350
* Booking Holdings Inc : Mizuho cuts price target to $1700 from $1720
* Booking Holdings Inc : RBC raises target price to $1,550 from $1,535
* Booking Holdings Inc : RBC raises target price to $1550 from $1535
* BorgWarner Inc : Citigroup raises price target to $30 from $23
* BorgWarner Inc : Credit Suisse raises target price to $33 from $31
* Bottomline Technologies (De) Inc : Citigroup raises price target to $46 from $43
* Bright Horizons Family Solutions Inc : Citigroup raises PT to $122 from $80
* Brightsphere Investment Group Inc : Evercore ISI raises target to $9 from $6
* Brightsphere Investment Group Inc : KBW raises target price to $9.50 from $7.25
* Brightview Holdings Inc : Credit Suisse cuts target price to $14 from $18
* Brightview Holdings Inc : Jefferies raises target price to $14 from $12
* Cabot Microelectronics Corp : Citigroup cuts price target to $140 from $175
* Cactus Inc : zephirin Group raises price objective to $12 from $8
* Calithera Biosciences Inc : Jefferies raises target price to $9 from $6
* Calyxt Inc : BMO cuts price target to $7 from $13
* Calyxt Inc : BMO cuts to market perform from outperform
* Camping World Holdings Inc : Credit Suisse raises target price to $12 from $11
* Camping World Holdings Inc : JP Morgan raises price target to $11 from $10
* Capstar Financial Holdings Inc : KBW raises target price to $11 from $10.50
* Cargurus Inc : BTIG raises target price to $26 from $23
* Carrols Restaurant Group Inc : Craig-Hallum raises to buy from hold; raises target price to $5 from $3.75
* Castlight Health Inc : Cantor Fitzgerald cuts target price to $1 from $2
* Catasys Inc : Canaccord Genuity raises target price to $36 from $35
* CBRE Group Inc : Evercore ISI cuts target price to $48 from $50
* CBRE Group Inc : KBW cuts target price to $51 from $52
* Centerpoint Energy Inc : Guggenheim raises target price to $26 from $25
* Centerpoint Energy Inc : Keybanc raises target price to $16 from $12
* Centurylink Inc : RBC cuts target price to $10 from $14
* CF Industries Holdings Inc : Citigroup cuts price target to $29 from $31
* CF Industries Holdings Inc : Scotiabank raises target price to $32 from $31
* ChannelAdvisor Corp : Needham raises price target to $14 from $11
* Charles River Laboratories International : Credit Suisse cuts PT to $159 from $162
* Charles River Laboratories International : Evercore ISI ups PT to $176 from $154
* Charles River Laboratories International : Jefferies raises PT to $161 from $139
* Charles River Laboratories International Inc : Citigroup raises price target to $190 from $165
* Chart Industries Inc : zephirin Group raises price objective to $25 from $17
* Charter Communications Inc : Benchmark raises price target to $600 from $523
* Chemours Co : Citigroup raises price target to $13 from $8
* Cimarex Energy Co : MKM Partners raises target price to $34 from $31
* City Holding Co : Stephens cuts target price to $63 from $64.
- 05/08/2020
|
Colfax Corp (CFX) Q1 2020 Earnings Call Transcript
- CFX earnings call for the period ending March 31, 2020.
- 05/08/2020
|
Colfax (CFX) Beats Q1 Earnings Estimates, Withdraws View
|
Edited Transcript of CFX earnings conference call or presentation 7-May-20 12:00pm GMT
- Q1 2020 Colfax Corp Earnings Call
- 05/07/2020
|
Travel Sites Take a Hit from the Pandemic -- Earnings at a Glance
|
Colfax shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.
|
Colfax (CFX) Beats Q1 Earnings and Revenue Estimates
- Colfax (CFX) delivered earnings and revenue surprises of 2.70% and 3.05%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
- 05/07/2020
|
Colfax Q1 Adj. EPS $0.380 Beats $0.370 Estimate, Sales $816.000M Beat $798.800M Estimate
|
Colfax Reports First Quarter 2020 Results
- • Reported $0.06 EPS from continuing operations and achieved $0.38 of adjusted EPS • Sustained strong momentum in the first two months of the year •.
- 05/07/2020
|
COVID-19 Impact and Recovery Analysis- Metal Cutting Tools Market 2020-2024 | Growth in Automotive Industry to Boost Growth | Technavio
- The metal cutting tools market is poised to grow by 10.24 bn during 2020-2024, according to Technavio
- 05/07/2020
|
Industrial Stocks' May 7 Earnings Roster: BLL, AAXN & More
- A peak at how some industrials are expected to fare this earnings season amid the coronavirus impact.
- 05/06/2020
|
Cooke & Bieler Lp Buys Essent Group, Alleghany Corp, U.S. ...
|
Shares of several industrial companies are trading lower on market weakness as investor uncertainty grows following quarterly earnings results from multiple companies.
|
Analysis on New Product Launches in Covid-19 Related Markets-Welding Equipment Market 2020-2024 | Use of Friction Stir Welding Technology to Boost Growth | Technavio
- The welding equipment market size will grow by $2.54 billion during 2020-2024.
- 04/30/2020
|
Earnings Preview: Colfax (CFX) Q1 Earnings Expected to Decline
- Colfax (CFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/30/2020
|
Earnings Preview: Colfax (CFX) Q1 Earnings Expected to Decline
- Colfax (CFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/30/2020
|
COVID-19 Creates A Window Of Opportunity With Lincoln Electric
- Lincoln Electric was already seeing a downturn before COVID-19, and now, business has taken a sharper turn downward. The U.S. business saw a 40% decline in orde
- 04/30/2020
|
Colfax Corporation’s (NYSE:CFX) Investment Returns Are Lagging Its Industry
- Today we'll evaluate Colfax Corporation (NYSE:CFX) to determine whether it could have potential as an investment idea...
- 04/30/2020
|
Colfax Target of Unusually High Options Trading (NYSE:CFX)
- Colfax Corp (NYSE:CFX) was the target of unusually large options trading activity on Tuesday. Traders purchased 723 call options on the stock. This represents an increase of approximately 1,191% compared to the average volume of 56 call options. NYSE:CFX opened at $27.20 on Thursday. Colfax has a one year low of $12.23 and a one […]
- 04/30/2020
|
Colfax (CFX) Scheduled to Post Earnings on Thursday
- Colfax (NYSE:CFX) is scheduled to announce its earnings results before the market opens on Thursday, May 7th. Analysts expect the company to announce earnings of $0.37 per share for the quarter. Colfax has set its FY 2020 Pre-Market guidance at 2.10-2.20 EPS and its FY20 guidance at $2.10-2.20 EPS.Investors that are interested in registering for […]
- 04/30/2020
|
Earnings Preview: Colfax (CFX) Q1 Earnings Expected to Decline
|
Global Metal Machining Market 2020-2024 | Evolving Opportunities with AMADA HOLDINGS Co. Ltd. and Atlas Copco AB | Technavio
- The global metal machining market has the potential to grow by USD 14.76 billion during 2020-2024
- 04/29/2020
|
Wally Weitz's Partners III Opportunity Fund 1st-Quarter Commentary
- Wally Weitz's Partners III Opportunity Fund 1st-Quarter Commentary, Stocks: LSE:EVRA,AMZN,EXPE,CFX,BRK.B,LBTYA,DXC,RWT,VMC, Wallace Weitz, release date:Apr 28, 2020
- 04/28/2020
|
Wally Weitz Comments on Colfax
- Wally Weitz Comments on Colfax, Stocks: CFX, Wallace Weitz, release date:Apr 28, 2020
- 04/28/2020
|
Wally Weitz's Hickory Fund 1st-Quarter Commentary
- Wally Weitz's Hickory Fund 1st-Quarter Commentary, Stocks: LSE:EVRA,EQC,IEX,RWT,CFX,PRSP,FBHS,LICT,BKI,EXPE,, Wallace Weitz, release date:Apr 28, 2020
- 04/28/2020
|
Colfax (CFX) Surges: Stock Moves 6.1% Higher
- Colfax (CFX) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
- 04/28/2020
|
Colfax (CFX) Surges: Stock Moves 6.1% Higher
- Colfax (CFX) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
- 04/28/2020
|
How tackling HIV taught San Francisco to cope with coronavirus
- San Francisco has escaped the worst of the coronavirus. Does its experience with HIV help us understand why?
- 04/28/2020
|
Wally Weitz's Partners III Opportunity Fund –st-Quarter Commentary
|
Colfax Corporation to Hold 2020 Annual Meeting of Stockholders in Virtual Format Due to COVID-19 Precautions
- Colfax Corporation (CFX), a leading diversified technology company, today announced that due to public health considerations arising from the coronavirus outbreak (COVID-19) and to support the health and well-being of its stockholders and employees, the format of the Annual Meeting has been changed and now will be held solely by means of remote communication, in a virtual format. Stockholders will not be able to attend the Annual Meeting in person. As described in the proxy materials for the Annual Meeting previously distributed, stockholders at the close of business on April 2, 2020, the record date, are entitled to participate in and vote at the Annual Meeting.
- 04/27/2020
|
Colfax Corporation to Hold 2020 Annual Meeting of Stockholders in Virtual Format Due to COVID-19 Precautions
- ANNAPOLIS JUNCTION, MD , April 27, 2020 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced...
- 04/27/2020
|
Global Medical Lifting Sling Market Analysis, 2019-2027 - Increasing Patient Safety Concerns Boosting Usage and Driving Growth
- Dublin, April 27, 2020 -- The "Global Medical Lifting Sling Market 2019-2027" report has been added to ResearchAndMarkets.com's offering.The global medical lifting.
- 04/27/2020
|
Colfax Corporation to Hold —…—… Annual Meeting of Stockholders in Virtual Format Due ...
|
Some Colfax (NYSE:CFX) Shareholders Have Copped A Big 54% Share Price Drop
- Colfax Corporation (NYSE:CFX) shareholders should be happy to see the share price up 22% in the last month. But that...
- 04/26/2020
|
Colfax Schedules First Quarter 2020 Earnings Release and Conference Call
- Colfax Corporation (CFX), a leading diversified technology company, today announced that it will issue a press release providing financial results for the first quarter of 2020 on the morning of Thursday, May 7, 2020. The Company will hold a conference call to discuss these results beginning at 8:00 a.m. Eastern on that day, which will be open to the public by calling +1-877-303-7908 (U.S. callers) and +1-678-373-0875 and referencing the conference ID number 1898585 and through webcast via Colfax’s website www.colfaxcorp.com under the “Investors” section. Colfax’s financial results press release and supplemental information referenced on the call, if any, for the first quarter of 2020 will be available under the “Investors” section of Colfax’s website prior to the conference call.
- 04/23/2020
|
Colfax Schedules First Quarter 2020 Earnings Release and Conference Call
- Annapolis Junction, MD, April 23, 2020 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that...
- 04/23/2020
|
Coronavirus news from the Bay Area: April 23-24
- The Chronicle began covering the coronavirus crisis before the first cases were reported in the Bay Area and a pandemic was declared. We reorganized the newsroom to dedicate nearly every resource to stories focusing on the health and economic disasters. Every day we have published live updates to reflect the most critical local, national and global updates on COVID-19, and this news is free of charge in an effort to keep our community safe and informed. • Read the previous batch of updates from April 21-22. • Read the next batch of updates for April 25. • See the full timeline. Updates from Friday, April 24: 9:35 p.m. Surge of strokes in coronavirus patients in 30s, 40s, doctors say: Some hospitals in the United States are reporting a surge of strokes in young and middle-aged patients with coronavirus, according to The Washington Post. Some medical centers, such as Mount Sinai Beth Israel Hospital in Manhattan and Johns Hopkins Hospital in Baltimore, are seeing more patients in their 30s or 40s who have the coronavirus and exhibited few symptoms, but still experienced or died from severe strokes. 8:47 p.m. San Francisco Unified School District adds five new pick-up sites for free meals: The district announced Friday it has partnered with five community organizations to...
- 04/23/2020
|
Optiva Appoints Ashish K Joshi as Chief Financial Officer
- Optiva Appoints Ashish K Joshi as Chief Financial Officer
- 04/21/2020
|
Is Colfax (NYSE:CFX) Using Too Much Debt?
- Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
- 04/19/2020
|
Colfax Corp (NYSE:CFX) Receives Consensus Rating of "Hold" from Analysts
- Colfax Corp (NYSE:CFX) has earned a consensus rating of “Hold” from the nineteen research firms that are presently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and ten have given a buy rating to the company. The average 12 month […]
- 04/19/2020
|
Investment Analysts' Recent Ratings Changes for Colfax (CFX)
- Several brokerages have updated their recommendations and price targets on shares of Colfax (NYSE: CFX) in the last few weeks: 4/15/2020 – Colfax had its price target raised by analysts at Morgan Stanley from $14.00 to $23.00. They now have an “equal weight” rating on the stock. 4/9/2020 – Colfax had its price target lowered […]
- 04/17/2020
|
Hennessy Advisors Inc. Invests $1.48 Million in Colfax Corp (NYSE:CFX)
- Hennessy Advisors Inc. acquired a new position in shares of Colfax Corp (NYSE:CFX) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 74,600 shares of the industrial products company’s stock, valued at approximately $1,477,000. Hennessy Advisors Inc. owned approximately 0.06% […]
- 04/16/2020
|
$792.19 Million in Sales Expected for Colfax Corp (NYSE:CFX) This Quarter
- Wall Street brokerages expect that Colfax Corp (NYSE:CFX) will announce $792.19 million in sales for the current fiscal quarter, Zacks Investment Research reports. Five analysts have issued estimates for Colfax’s earnings, with the highest sales estimate coming in at $815.85 million and the lowest estimate coming in at $770.00 million. Colfax posted sales of $1.01 […]
- 04/16/2020
|
Colfax (CFX) Receives a Hold from Morgan Stanley
- Morgan Stanley analyst Joshua Pokrzywinski maintained a Hold rating on Colfax (CFX) today and set a price target of $23.00. The company's shares closed
- 04/15/2020
|
Shares of several industrial companies are trading lower as equities fall amid mixed earnings results from banks, a significant decline in the price of oil and worse than expected retail sales in March.
|
'It could have been averted': How 92 residents at a San Francisco homeless shelter got Covid-19
- Outbreak at MSC South shelter comes after weeks of advocates warning city it needed to do more to protect homeless people
- 04/15/2020
|
Morgan Stanley Maintains Equal-Weight on Colfax, Raises Price Target to $23
|
Deutsche Bank Lowers Colfax (NYSE:CFX) Price Target to $19.00
- Colfax (NYSE:CFX) had its price target decreased by Deutsche Bank from $41.00 to $19.00 in a research note issued to investors on Thursday, BenzingaRatingsTable reports. Deutsche Bank currently has a hold rating on the industrial products company’s stock. Several other research analysts have also commented on the company. Morgan Stanley lowered their price target on […]
- 04/13/2020
|
Shares of several industrial companies are trading lower amid overall market weakness. The coronavirus has caused global macro disruption, which has been a negative catalyst for the sector as output and investment outlook is hampered.
|
Geode Capital Management LLC Buys 40,300 Shares of Colfax Corp (NYSE:CFX)
- Geode Capital Management LLC boosted its stake in shares of Colfax Corp (NYSE:CFX) by 4.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 952,048 shares of the industrial products company’s stock after buying an additional 40,300 shares during the quarter. Geode […]
- 04/11/2020
|
Alliancebernstein L.P. Boosts Stake in Colfax Corp (NYSE:CFX)
- Alliancebernstein L.P. grew its stake in Colfax Corp (NYSE:CFX) by 3.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 144,895 shares of the industrial products company’s stock after acquiring an additional 4,680 shares during the period. Alliancebernstein L.P. owned 0.12% of […]
- 04/10/2020
|
Deutsche Bank Reaffirms Their Hold Rating on Colfax (CFX)
- In a report released today, Nicole Deblase from Deutsche Bank maintained a Hold rating on Colfax (CFX), with a price target of $19.00. The company's
- 04/09/2020
|
Stanley Black & Decker (NASDAQ:CFXA) Stock Price Up 8.6%
- Stanley Black & Decker (NASDAQ:CFXA) rose 8.6% during mid-day trading on Wednesday . The stock traded as high as $104.74 and last traded at $103.95, approximately 28,600 shares were traded during trading. A decline of 46% from the average daily volume of 52,991 shares. The stock had previously closed at $95.76. Separately, TheStreet lowered shares […]
- 04/09/2020
|
The Global Waterjet Cutting Machinery Market is expected to grow from USD 873.74 Million in 2018 to USD 1,398.89 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.95%
- New York, April 09, 2020 -- Reportlinker.com announces the release of the report "Global Waterjet Cutting Machinery Market - Premium Insight, Competitive News Feed Analysis,.
- 04/09/2020
|
Deutsche Bank Maintains Hold on Colfax, Lowers Price Target to $19
|
World Industrial Pump Market Nears $100 Billion by 2027 - Technological Advancements have Resulted in Increased Efficiency, Driving Adoption
- The "Industrial Pump Market Size, Share & Trends Analysis Report by Product (Centrifugal, Positive Displacement), by Application (Oil & Gas, Water & Wastewater, Power), and Segment Forecasts, 2020-2027" report has been added to ResearchAndMarkets.com's offering.
- 04/08/2020
|
Global Industrial Pump Market Analysis & Outlook, 2020-2027 - ResearchAndMarkets.com
- The "Industrial Pump Market Size, Share & Trends Analysis Report by Product (Centrifugal, Positive Displacement), by Application (Oil & Gas, Water & Wastewater, Power), and Segment Forecasts, 2020-2027" report has been added to ResearchAndMarkets.com's offering.
- 04/08/2020
|
Colfax (NYSE:CFX) Shares Gap Up to $20.12
- Colfax Corp (NYSE:CFX)’s stock price gapped up before the market opened on Tuesday . The stock had previously closed at $22.78, but opened at $20.12. Colfax shares last traded at $21.58, with a volume of 74,424 shares. CFX has been the subject of several analyst reports. CIBC raised Colfax to an “outperformer” rating and upped […]
- 04/08/2020
|
Does Colfax’s (NYSE:CFX) Statutory Profit Adequately Reflect Its Underlying Profit?
- It might be old fashioned, but we really like to invest in companies that make a profit, each and every year. Having...
- 04/07/2020
|
Profund Advisors LLC Invests $216,000 in Colfax Corp (NYSE:CFX)
- Profund Advisors LLC acquired a new stake in shares of Colfax Corp (NYSE:CFX) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 5,930 shares of the industrial products company’s stock, valued at approximately $216,000. A number of other hedge funds also […]
- 04/07/2020
|
Are Hedge Funds Going To Get Burned By Ternium S.A. (TX) ?
- We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- 04/07/2020
|
Hedge Funds Have Never Been More Bullish On PLDT Inc. (PHI)
- We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- 04/07/2020
|
Shares of several industrial companies are trading higher amid optimism that coronavirus cases in Asia are potentially easing. Strength may also be attributed to optimism that coronavirus cases in several US hotspots appear to be reaching their peak.
|
Colfax Corp (NYSE:CFX) to Post Q1 2020 Earnings of $0.37 Per Share, Northcoast Research Forecasts
- Colfax Corp (NYSE:CFX) – Northcoast Research dropped their Q1 2020 earnings per share estimates for Colfax in a note issued to investors on Thursday, April 2nd. Northcoast Research analyst T. Hayes now anticipates that the industrial products company will post earnings per share of $0.37 for the quarter, down from their prior estimate of $0.43. […]
- 04/06/2020
|
Cubist Systematic Strategies LLC Purchases 16,337 Shares of Colfax Corp (NYSE:CFX)
- Cubist Systematic Strategies LLC lifted its position in shares of Colfax Corp (NYSE:CFX) by 114.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,603 shares of the industrial products company’s stock after acquiring an additional 16,337 shares during the period. Cubist […]
- 04/05/2020
|
How Greater Baltimore stocks fared during a tumultuous first quarter
- One public company based in Greater Baltimore raised its stock price during a tumultuous first quarter for the financial markets. Baltimore-based Legg Mason Inc. saw its stock price increase 35% to $48.
- 04/03/2020
|
Bank of New York Mellon Corp Raises Position in Colfax Corp (NYSE:CFX)
- Bank of New York Mellon Corp increased its holdings in Colfax Corp (NYSE:CFX) by 5.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 879,966 shares of the industrial products company’s stock after purchasing an additional 48,331 shares during the quarter. […]
- 04/03/2020
|
Colfax (NYSE:CFX) Shares Down 12.3% After Analyst Downgrade
- Colfax Corp (NYSE:CFX)’s share price was down 12.3% on Wednesday after Citigroup lowered their price target on the stock from $29.00 to $18.00. Citigroup currently has a sell rating on the stock. Colfax traded as low as $16.74 and last traded at $17.37, approximately 2,133,046 shares traded hands during mid-day trading. An increase of 29% […]
- 04/02/2020
|
Shares of several industrial companies are trading lower amid market weakness as macro concerns continue to grow as a result of the coronavirus pandemic. The White House said it expects a surge in coronavirus cases over the next 2 weeks.
|
Bank of America Corp DE Cuts Stock Holdings in Colfax Corp (NYSE:CFX)
- Bank of America Corp DE lowered its stake in shares of Colfax Corp (NYSE:CFX) by 15.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 540,070 shares of the industrial products company’s stock after selling 99,057 shares during the quarter. Bank of America Corp DE […]
- 04/01/2020
|
Citigroup Maintains Sell on Colfax, Lowers Price Target to $18
|
Amundi Pioneer Asset Management Inc. Makes New $381,000 Investment in Colfax Corp (NYSE:CFX)
- Amundi Pioneer Asset Management Inc. purchased a new position in shares of Colfax Corp (NYSE:CFX) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 10,465 shares of the industrial products company’s stock, valued at approximately $381,000. A number of other large investors […]
- 03/31/2020
|
Royce Global Value Trust (NYSE: RGT) as of Feb 29, 2020
- A closed-end fund that invests in global equities using a disciplined value approach
- 03/30/2020
|
Royce Value Trust (NYSE: RVT) as of Feb 29, 2020
- Oldest and largest small-cap closed-end fund
- 03/30/2020
|
Brokers Issue Forecasts for Colfax Corp's Q1 2020 Earnings (NYSE:CFX)
- Colfax Corp (NYSE:CFX) – Analysts at Seaport Global Securities decreased their Q1 2020 EPS estimates for Colfax in a research note issued to investors on Wednesday, March 25th. Seaport Global Securities analyst W. Liptak now anticipates that the industrial products company will earn $0.42 per share for the quarter, down from their previous forecast of […]
- 03/30/2020
|
Hedge Funds Have Never Been This Bullish On Sabra Health Care REIT Inc (SBRA)
- Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […]
- 03/29/2020
|
Hedge Funds Have Never Been This Bullish On New Jersey Resources Corp (NJR)
- Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […]
- 03/29/2020
|
Hedge Funds Have Never Been This Bullish On Colfax Corporation (CFX)
- Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […]
- 03/29/2020
|
Colfax (CFX) Displays Bright Prospects, Headwinds Remain
- Colfax (CFX) is likely to benefit from its focus on strengthening segmental businesses, productivity actions and acquisitions. However, rising cost of sales and high debt remain concerns.
- 03/27/2020
|
Colfax (CFX) Displays Bright Prospects, Headwinds Remain
- Colfax (CFX) is likely to benefit from its focus on strengthening segmental businesses, productivity actions and acquisitions. However, rising cost of sales and high debt remain concerns.
- 03/27/2020
|
Is Colfax Corporation (NYSE:CFX) A Volatile Stock?
- Anyone researching Colfax Corporation (NYSE:CFX) might want to consider the historical volatility of the share price...
- 03/27/2020
|
Shares of several companies in the broader industrial sector are trading lower as markets sell off following this week's strength. Despite US stimulus efforts, macro concerns still persist due to the coronavirus.
|
Goldman Sachs Group Inc. Cuts Holdings in Colfax Corp (NYSE:CFX)
- Goldman Sachs Group Inc. lessened its stake in Colfax Corp (NYSE:CFX) by 25.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,213,955 shares of the industrial products company’s stock after selling 409,890 shares during the period. Goldman Sachs […]
- 03/26/2020
|
Colfax Corp (NYSE:CFX) Receives Consensus Recommendation of "Buy" from Analysts
- Colfax Corp (NYSE:CFX) has been given an average rating of “Buy” by the seventeen analysts that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have issued a buy rating on the company. The average twelve-month price target […]
- 03/25/2020
|
Amalgamated Bank Acquires 2,503 Shares of Colfax Corp (NYSE:CFX)
- Amalgamated Bank increased its holdings in shares of Colfax Corp (NYSE:CFX) by 13.1% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 21,576 shares of the industrial products company’s stock after purchasing an additional 2,503 shares during the quarter. Amalgamated Bank’s holdings in Colfax were worth $785,000 at the end of the most recent […]
- 03/24/2020
|
ProShare Advisors LLC Purchases New Position in Colfax Corp (NYSE:CFX)
- ProShare Advisors LLC purchased a new stake in shares of Colfax Corp (NYSE:CFX) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 7,497 shares of the industrial products company’s stock, valued at approximately $273,000. A number of other large investors have […]
- 03/24/2020
|
Zacks: Brokerages Anticipate Colfax Corp (NYSE:CFX) Will Announce Quarterly Sales of $833.08 Million
- Brokerages expect Colfax Corp (NYSE:CFX) to report $833.08 million in sales for the current quarter, Zacks reports. Six analysts have provided estimates for Colfax’s earnings. The lowest sales estimate is $818.80 million and the highest is $846.70 million. Colfax reported sales of $1.01 billion during the same quarter last year, which would suggest a negative […]
- 03/24/2020
|
What Kind Of Share Price Volatility Should You Expect For Colfax Corporation (NYSE:CFX)?
- If you own shares in Colfax Corporation (NYSE:CFX) then it's worth thinking about how it contributes to the volatility...
- 03/23/2020
|
Is Colfax (CFX) a Great Value Stock Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 03/23/2020
|
Is Colfax (CFX) a Great Value Stock Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 03/23/2020
|
Enersys Gains From Solid Demand & Buyouts Amid Cost Woes
- Enersys (ENS) benefits from strength in its transportation business, solid demand for NexSys TPPL products and buyout of Alpha Technologies. However, rising cost of sales and high debt remain concerns.
- 03/23/2020
|
Enersys Gains From Solid Demand & Buyouts Amid Cost Woes
- Enersys (ENS) benefits from strength in its transportation business, solid demand for NexSys TPPL products and buyout of Alpha Technologies. However, rising cost of sales and high debt remain concerns.
- 03/23/2020
|
Envestnet Asset Management Inc. Purchases 4,764 Shares of Colfax Corp (NYSE:CFX)
- Envestnet Asset Management Inc. boosted its position in Colfax Corp (NYSE:CFX) by 18.7% during the 4th quarter, Holdings Channel.com reports. The fund owned 30,259 shares of the industrial products company’s stock after buying an additional 4,764 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Colfax were worth $1,101,000 at the end of the […]
- 03/23/2020
|
